Vascular Medicine
PE diagnosis, treatment, and risk stratification
Also called PE, pulmonary thromboembolism, VTE
Sources: updated Oct 2, 2026
Specific, answerable questions in this area — each with its own synthesized evidence and consensus. Open one to see the forest plot, source trials, and how the consensus has changed over time.
Does anticoagulation vs placebo improve outcomes in Pulmonary Embolism?
Low CertaintyNo benefit shownanticoagulation vs placebo · Cardiac Output
Does anticoagulation vs placebo improve Hospital Length of Stay in Pulmonary Embolism?
Low CertaintyNo benefit shownanticoagulation vs placebo · Hospital Length of Stay
Synthesized from 4 evidence-backed clinical questions on Pulmonary embolism — 4 no benefit shown.
The placed evidence leans toward no benefit
0
Favor benefit
0% of all
4
No benefit shown
100% of all
Low certainty on 100% of questions
Does anticoagulation vs placebo improve outcomes in Pulmonary Embolism?
Low Certainty− No benefit shownanticoagulation vs placebo · Cardiac Output
17 studies (14,692 patients) provide low-certainty evidence against benefit of anticoagulation for Cardiac Output in Pulmonary Embolism.
Does anticoagulation vs placebo improve Hospital Length of Stay in Pulmonary Embolism?
Low Certainty− No benefit shownanticoagulation vs placebo · Hospital Length of Stay
3 studies (8,097 patients) provide low-certainty evidence against benefit of anticoagulation for Hospital Length of Stay in Pulmonary Embolism.
Direction changes backed by at least one randomized trial on each side.
Follow this topic to get this summary as a weekly digest.
The evidence sections above show what the literature supports; this is what the field is still arguing about. Open a debate for the camps, the named voices, and the vote.
A clinical question appears here only when its condition matches this topic, an outcome and a comparator were extracted from the studies, at least two studies and a patient count are on file, and the certainty is low or higher.
Supports benefit, no benefit shown, and mixed describe the direction of the measured effect. No benefit shown means the evidence does not support a benefit. It is not a finding of harm. Too little evidence means the question did not clear that bar.
Study count, RCT count, and patient count are separate. The patient total adds only studies that are linked into a study family and whose sample size is not flagged as implausible. A reversal is listed only when at least one randomized trial sits on each side of the change.
The overview is drafted from the guideline recommendations, trials, papers, and questions on this page, and every sentence has to cite one of them. It stays unverified until an NPI-verified clinician or a Synapse admin approves it. Approving records that person's name.
Cleveland Clinic
h-index 179 · 218k citations
Most-cited researchers publishing on Pulmonary embolism.
